Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RGS9 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | COQ8A | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | ATP6V1B2 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
mRNA | UBL3 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
mRNA | ITGB2 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | TRPM2 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | OSBPL11 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | B3GNT8 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | OVOL1 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
mRNA | ANKRD13D | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |